• Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • Jul 19 2022
  • Duración: 10 m
  • Podcast

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • Resumen

  • Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

    Read the full article:
    Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.